Phase III: CERVIVA CARG

The Collaborative Applied Research Grants are programmatic awards to support teams of high-calibre researchers from academia, health and social services, population health and/or policy institutions who have an existing and impressive track record in applied health services and/or population health research. Collaborative Applied Health Research, as defined for the purposes of this scheme, is research with an emphasis on providing evidence to improve health outcomes for individuals, communities and populations, typically thorough improved healthcare and better health care delivery.

Raman spectroscopy

Workstream: 

  • Phase III: CERVIVA CARG
Technology and computing

Ongoing work as part of CERVIVA, funded by Enterprise Ireland [EI] has been developing a novel tool for cervical cancer screening based on Raman spectroscopy. Raman spectroscopy is a powerful tool that can generate a biochemical fingerprint of a sample in a rapid and non-destructive manner. Raman spectroscopy is an optical method based on inelastic light scattering.

ECHO (Epidemiology of HPV infection in Oral cancer in Ireland)

Workstream: 

  • Phase III: CERVIVA CARG
A happy old couple

Human papillomavirus (HPV) is the single most important aetiological agent in the pathogenesis of cervical cancer and pre-cancer. It is increasingly recognised that HPV is causally implicated in other cancers, including head and neck cancer. The incidence of head and neck cancer, and more specifically oropharyngeal cancer, has been increasing over the last decade.

Subscribe to RSS - Phase III: CERVIVA CARG